Latest Articles
21 hours, 50 minutes ago
Magic’s Vince Carter not concerned about ‘individual stuff’
The points have piled up over the years at such an impressive pace that he has lost track.
OrlandoSentinel.com - Sports - 4:31 p.m. Monday 15th March 2010 PDT
View Article
Related Articles
Email to Friend
Merck blood thinner appears safe, effective-study
An experimental blood thinner being developed by Merck & Co from a new class of drugs appeared to be safe and effective in a mid-stage study that compared three doses ...
WN.com - World News - 6:40 a.m. Monday 15th March 2010 PDT
View Article
Related Articles
Email to Friend
1 day, 20 hours ago
ACC: Rosuvastatin and Ezetimibe Combo Tops LDL Trial (CME/CE)
ATLANTA (MedPage Today) -- More than 95% of patients taking a high dose rosuvastatin (Crestor) plus ezetimibe (Zetia) combination reached low-density lipoprotein (LDL) goals of less than 100 mg/dl -- ...
MedPageToday - 6:08 p.m. Sunday 14th March 2010 PDT
View Article
Related Articles
Email to Friend
ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation
ATLANTA, Georgia, March 14, 2010 /PRNewswire/ -- Cardiovascular risk can be reduced by an additional 31 percent in type 2 diabetes patients with atherogenic dyslipidemia, the common combination of elevated ...
RedOrbit - health - 7:50 a.m. Sunday 14th March 2010 PDT
View Article
Related Articles
Email to Friend
4 days, 7 hours ago
FDA Approves Watson Pharmaceuticals, Inc.'s TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
MORRISTOWN, N.J., March 11 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE:WPI - News), today announced the U.S. Food and Drug Administration (FDA) approval of TRELSTAR 22.5 mg (triptorelin pamoate for injectable ...
BioSpace - 7:17 a.m. Friday 12th March 2010 PST
View Article
Related Articles
Email to Friend
5 days, 2 hours ago
FDA Approves Watson's TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
MORRISTOWN, N.J., March 11 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI), today announced the U.S.
RedOrbit - health - 12:15 p.m. Thursday 11th March 2010 PST
View Article
Related Articles
Email to Friend
5 days, 17 hours ago
Madonna Planning Fashion Line With Daughter Lourdes
Madonna has teamed up with her teenage daughter to create a fashion line for young women. The pop superstar is launching her own style empire, called MG Icon, and she ...
Starpulse Entertainment News Blog - 8:48 p.m. Wednesday 10th March 2010 PST
View Article
Related Articles
Email to Friend
Madonna to launch fashion line this summer
After high profile-stints as the face of luxury labels like Dolce & Gabbana, it was only a matter of time before Madonna stepped behind the scenes to design her own ...
Entertainment Weekly's PopWatch - 1:23 p.m. Wednesday 10th March 2010 PST
View Article
Related Articles
Email to Friend
Madonna's Next Role? Fashion Designer!
The pop star is launching her own style empire, MG Icon
People.com: Top Headlines - 11:15 a.m. Wednesday 10th March 2010 PST
View Article
Related Articles
Email to Friend
'AiDKlinik' Reduces Risks For ICU Patients
The electronic drug information system “AiDKlinik” reduces the number of adverse drug interactions and adverse eventsTo get life-threatening diseases under control, patients in the intensive care unit usually are administered ...
RedOrbit - health - 7:42 a.m. Wednesday 10th March 2010 PST
View Article
Related Articles
Email to Friend
